Cargando…
Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases
OBJECTIVE: The European Association of Urology (EAU) recommends a bone scan for newly diagnosed unfavorable intermediate- and high-risk prostate cancer. We aimed to validate the screening criteria for bone metastases in patients with treatment-naïve prostate cancer. METHODS: This single-center retro...
Autores principales: | Rud, Erik, Noor, Daniyal, Galtung, Kristina Flor, Ottosson, Fredrik, Jacewicz, Maciej, Baco, Eduard, Lauritzen, Peter Mæhre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705459/ https://www.ncbi.nlm.nih.gov/pubmed/35939081 http://dx.doi.org/10.1007/s00330-022-08945-7 |
Ejemplares similares
-
The prevalence and locations of bone metastases using whole-body MRI in treatment-naïve intermediate- and high-risk prostate cancer
por: Ottosson, Fredrik, et al.
Publicado: (2020) -
Role of radiomic analysis of [(18)F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging
por: Marturano, Francesca, et al.
Publicado: (2023) -
Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship
por: Giganti, Francesco, et al.
Publicado: (2022) -
MRI of the kidney—state of the art
por: Nikken, J. J., et al.
Publicado: (2007) -
Appearance of abdominal wall endometriosis on MR imaging
por: Busard, Milou P. H., et al.
Publicado: (2009)